Key facts
- This page summarizes Gene Z. Salkind's Form 4 filing for Avenir Wellness Solutions, Inc. (AVRW).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Aug 2023, 18:24.
Gene Z. Salkind - 23 Sep 2021 Form 4 Insider Report for Avenir Wellness Solutions, Inc. (AVRW)
- Reporting relationship
- Director
- Issuer ticker
- AVRW
- Reported as of
- 23 Sep 2021
- Net transaction value
- +$31,176
- SEC form
- 4
- Accepted by SEC
- 25 Aug 2023, 18:24:16 UTC
- Prior SEC filing
- 27 May 2021
- Next SEC filing
- 21 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gene Z. Salkind
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gene Z. Salkind filed Form 4 for Avenir Wellness Solutions, Inc. (AVRW) on 25 Aug 2023.
Change
- Previous filing in this sequence was filed on 27 May 2021.
- Current net transaction value: +$31,176.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AVRW
transaction
Common Stock
Options Exercise
- Transaction value
- $31,176
- Shares
- +117,647
- Change %
- Price
- $0.2650
- Shares after
- 117,647
- Date
- 23 Sep 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AVRW
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +117,647
- Change %
- Price
- $0.000000
- Shares after
- 117,647
- Date
- 23 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 117,647
- Exercise price
- $0.7000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan pursuant to the Issuer's Non-Employee Director Compensation Policy. The RSUs will vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service through the vesting date. The RSUs will vest in full immediately prior to the consummation of a change in control of the Issuer. The RSUs will be settled in shares of the Issuer's common stock upon vesting.
Footnote F2
N/A